Molecular characteristics of breast cancer according to clinicopathological factors.
In conclusion, BRCA1 mutation was associated with TNBC and the luminal B HER2 (-) subtype. HER2-positive subtypes were characteristic of the control group. CHEK2 and NOD2 mutation carriers had a more favorable profile of prognostic factors.
PMID: 31281656 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Huszno J, Kolosza Z Tags: Mol Clin Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | HER2 | Study